Zoetis Inc. ( ZTS) - Key Metrics
ZTS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $5.81 | $1.44 | $2 | $1.74 |
| 2026Q2 | $5.91 | $1.65 | $1.57 | $1.29 |
| 2026Q1 | $5.36 | $1.42 | $0.95 | $0.69 |
| 2025Q4 | $5.45 | $1.38 | $2.04 | $1.67 |
| 2025Q3 | $5.42 | $1.63 | $2.12 | $1.82 |
ZTS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 37.06% | 12.12 |
| 2026Q2 | 32.27% | 10.89 |
| 2026Q1 | 37.27% | 20.81 |
| 2025Q4 | 36.48% | 22.79 |
| 2025Q3 | 30.79% | 22.44 |
ZTS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 2.49% | 0.76% |
| 2026Q2 | 1.79% | 0.74% |
| 2026Q1 | 0.58% | 0.45% |
| 2025Q4 | 1.33% | 0.40% |
| 2025Q3 | 1.24% | 0.34% |
ZTS
List: Contenders
Price: $79.73
Dividend Yield: 2.53%
Forward Dividend Yield: 2.66%
Payout Ratio: 33.88%
Dividend Per Share: 2.12 USD
Earnings Per Share: 5.88 USD
P/E Ratio: 14.04
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.6 million
Ebitda: 543.0 millionMarket Capitalization: 33.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 15.44%
DGR5: 20.27%
DGR10: 20.94%